Rifaximin MMX - phase 3 results?

Discussion in 'Santarus' started by Anonymous, Sep 8, 2011 at 11:24 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    Is thus study wrapped up? If not when should we expect to here results and submit for approval? This is going to be huge!!!
     

  2. Anonymous

    Anonymous Guest

    uhh..where have you been...that drug will never come to light due to lack of patients. Budesonide MMX will come to market and struggle.
     
  3. Anonymous

    Anonymous Guest

    Try blockbuster
     
  4. Anonymous

    Anonymous Guest

    Blockbuster? Name one product that has been a blockbuster at Santarus...one where the reps and management team have made a significant amount of money on and it has affected their share price?

    Bud. MMX will be marginal at best. GI docs have drugs that work almost as well that are generic. It will be a much more difficult sell than SNTS beleives it to be. Plus the salesforce just isnt strong enough to pull this product through. They are happy as bugs in a rug to just make salary and not make any money on their current products.

    For proof, check out sales results for 2011, 2010, 2009, 2008, 2007, 2006, 2005. Sales force has never hit a Year end goal with this organization. Ever.